In a new study, Yale researchers identified a novel genetic defect that prevents brain tumor cells from repairing damaged DNA. They found that the defect is highly sensitive to an existing FDA-approved drug used to treat ovarian cancer — a discovery that...
The U.S. Food and Drug Administration (FDA) has awarded Yale and Mayo Clinic a grant up to $6.7 million over two years to establish a Center of Excellence in Regulatory Science and Innovation (CERSI).The award will support a collaboration bridging the...
